RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Executive Officer Abraham Ceesay sold $143K of Rapport Therapeutics, Inc.
Sold$143,273
$31.68Price
4,522Shares
−1%Stake
What RAPP did after the filing
- The stock from Fri, Oct 9 open, $29.73
- −12.8%
- S&P 500, same days
- −2.1%
10 of 30 trading days so far, to the Oct 23 close.
Traded Tue, Oct 6. Filed Thu, Oct 8, 4:07 PM ET, after the close. Returns use the Oct 9 open and the Oct 23 close. Not investment advice.